(Q36348405)

13 August 2017

0 references

Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux (English)

1 reference

13 August 2017

0 references

1 reference

J H Rubenstein

1

1 reference

13 August 2017

J B Taylor

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

23 September 2010

1 reference

Alimentary Pharmacology & Therapeutics

13 August 2017

1 reference

13 August 2017

32

1 reference

13 August 2017

10

1 reference

13 August 2017

1222-1227

1 reference

A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Association of adiponectin multimers with Barrett's oesophagus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Leptin and the risk of Barrett's oesophagus.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric Cardia

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481544

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

5 December 2018

1 reference

12 December 2020

Subsite-specific risk factors for esophageal and gastric adenocarcinoma

1 reference

12 December 2020

A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma

1 reference

12 December 2020

Demographic variations in the rising incidence of esophageal adenocarcinoma in white males

1 reference

12 December 2020

10.1111/J.1365-2036.2010.04471.X

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

20955441

1 reference